Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | AR | P10275 | 1/20 | 0.38 |
| ▸ | PDE1B | Q01064 | 4/20 | 0.38 |
| ▸ | DCTPP1 | Q9H773 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.35 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.35 |
| ▸ | P2RX3 | P56373 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17357817 | 0.86 | LMNA (0.41) | LMNAL3MBTL1ARPDE1BDCTPP1 | |
| SCHEMBL17359641 | 0.84 | LMNA (0.42) | LMNAL3MBTL1ARDCTPP1KMT2A | |
| SCHEMBL17358144 | 0.84 | LMNA (0.40) | LMNAL3MBTL1ARPDE1BDCTPP1 | |
| SCHEMBL17358146 | 0.82 | LMNA (0.38) | LMNAL3MBTL1ARPDE1BDCTPP1 | |
| SCHEMBL17358010 | 0.81 | DCTPP1 (0.52) | LMNAL3MBTL1ARPDE1BDCTPP1 | |
| SCHEMBL17358016 | 0.81 | AR (0.46) | LMNAL3MBTL1ARPDE1BDCTPP1 | |
| SCHEMBL17357820 | 0.77 | HTT (0.49) | LMNAL3MBTL1ARPDE1BDCTPP1 | |
| SCHEMBL17357987 | 0.74 | RXFP1 (0.53) | LMNAPDE1BKMT2AGAAMAPT | |
| SCHEMBL17358145 | 0.70 | LMNA (0.42) | LMNAL3MBTL1ARKMT2AGAA | |
| SCHEMBL17359634 | 0.69 | LMNA (0.40) | LMNAL3MBTL1ARDCTPP1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9963451-B2 | Fused ring pyrimidine compound and pest control agent containing the same | MITSUI CHEMICALS AGRO, INC. (JP) | 2018-05-08 | — | — | US | disclosed |
| US-20150368249-A1 | FUSED RING PYRIMIDINE COMPOUND AND PEST CONTROL AGENT CONTAINING THE SAME | MITSUI CHEMICALS CROP & LIFE SOLUTIONS, INC. (JP) | 2015-12-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150368249-A1 | FUSED RING PYRIMIDINE COMPOUND AND PEST CONTROL AGENT CONTAINING THE SAME | CBR3, HRH2, HRH4 | LMNA 4402/4885L3MBTL1 132/4885AR 1794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.